These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag. Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA mBio; 2020 Jan; 11(1):. PubMed ID: 31964738 [TBL] [Abstract][Full Text] [Related]
11. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present. Uriu K; Kosugi Y; Ito J; Sato K Viruses; 2021 Jan; 13(1):. PubMed ID: 33477360 [TBL] [Abstract][Full Text] [Related]
12. Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection. Rashid F; Zaongo SD; Iqbal H; Harypursat V; Song F; Chen Y Front Immunol; 2024; 15():1390650. PubMed ID: 39221250 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly. Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF J Virol; 2017 May; 91(9):. PubMed ID: 28202763 [TBL] [Abstract][Full Text] [Related]
14. HIV accessory proteins versus host restriction factors. Strebel K Curr Opin Virol; 2013 Dec; 3(6):692-9. PubMed ID: 24246762 [TBL] [Abstract][Full Text] [Related]
15. Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. Stavrou S; Crawford D; Blouch K; Browne EP; Kohli RM; Ross SR PLoS Pathog; 2014 May; 10(5):e1004145. PubMed ID: 24851906 [TBL] [Abstract][Full Text] [Related]
20. The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle. Meng B; Lever AML Viruses; 2021 Feb; 13(2):. PubMed ID: 33672541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]